Ovarian serous borderline tumors with invasive peritoneal implants

Cancer

Volumn 82, Issue 6, 1998, Pages 1096-1103

  Gershenson, David M ^a,b   Silva, Elvio G ^a   Levy, Lawrence ^a   Burke, Thomas W ^a   Wolf, Judith K ^a   Tornos, Carmen ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Borderline tumors; Chemotherapy; Ovary; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; OVARY TUMOR; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0032520777     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1     Document Type: Article

References (28)

1. Taylor HC. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929;48:204-30.
2. Bamhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752-6.
3. Barnhill D, Heller P, Brzozowski P, Advani H, Gallup D, Park R. Epithelial ovarian carcinoma of low malignant potential. Obstet Gvnecol 1985;65:53-9.
4. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986;58:2052-65.
5. Kliman L, Rome RM, Fortune DW. Low malignant potential tumors of the ovary: a study of 76 cases. Obstet Gynecol 1986;68:338-44.
6. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990;65:578-85.
7. Rice LW, Berkowitz RS, Mark SD, Yavner DL, Lage JM. Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990;39:195-8.
8. Leake JF Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-8.
9. Manchul LA, Simm J, Levin W, Fyles AW, Dembo AJ, Pringle JF, et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phys 1992;22:867-74.
10. Kennedy AW, Hart WR. Ovarian papillary serous tumors ot low malignant potential (serous borderline tumors): a longterm follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996;78:278-86.
11. Kaern J, Tropé CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993; 71:1810-20.
12. Fort MG, Pierce VK, Saigo PE, Hoskins WJ, Lewis JL. Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989;32: 269-72.
13. Barakat RR, Benjamin I, Lewis JL, Saigo PE, Curtin JP, Hoskins WJ. Platinum-based chemotherapy for advanced stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol 1995;59:390-3.
14. Chambers JT, Merino MJ, Kohorn EI, Schwartz PE. Borderline ovarian tumors. Am J Obstet Gynecol 1988;159:1088-94.
15. Russell P. Borderline epithelial tumours of the ovary: a conceptual dilemma. Clin Obstet Gynecol 1984;11:259-77.
16. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 1986;57:1240-7.
17. McCaughey WTE, Kirk ME, Lester W, Dardick I. Peritoneal epithelial lesions associated with proliferative serous tumours of ovary. Histopathology 1984;8:195-208.
18. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 1988;62:2212-22.
19. Russell P, Merkur H. Proliferating ovarian "epithelial" tumours: a clinico-pathological analysis of 144 cases. Aust N Z J Obstet Gynecol 1979;19:45-55.
20. De Nictolis M, Montironi R, Tommasoni S, Carinelli S, Ojeda B, Matias-Guiu X, et al. Serous borderline tumors of the ovary. Cancer 1992;70:152-60.
21. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types: a clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20(11):1331-45.
22. Staging Announcement: FIGO Cancer Committee. Gynecol Oncol 1986;25:383-5.
23. SAS/STAT user guide, 1990. Cary, NC: SAS Institute, 1990.
24. Massad LS, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991;78:1027-32.
25. Nation JG, Krepart GV. Ovarian carcinoma of low malignant potential: staging and treatment. Am J Obstet Gynecol 1986; 154:290-3.
26. Hopkins MP, Kumar NB, Morley GW. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential. Obstet Gynecol 1987;70: 923-9.
27. Nikrui N. Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol Oncol 1981;12: 107-19.
28. O'Quinn AG, Hannigan EV. Epithelial ovarian neoplasms of low malignant potential. Gynecol Oncol 1985;21:177-85.